Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

about

Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects.

P2860

Q47825089-D97991FE-AAE1-42C9-B187-ECA0472AEE7F

P2860

Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

Item

http://www.wikidata.org/entity/Q48238673

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

@en

Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

@nl

type

Item

label

Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

@en

Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

@nl

prefLabel

Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

@en

Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

@nl

P1476

Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

@en

P2093

Emanuela Esposito

http://www.w3.org/2001/XMLSchema#string

Giuseppe Bruschetta

http://www.w3.org/2001/XMLSchema#string

Irene Paterniti

http://www.w3.org/2001/XMLSchema#string

Michela Campolo

http://www.w3.org/2001/XMLSchema#string

Rosalba Siracusa

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing

Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice

Mitochondrial dysfunction in Parkinson's disease

The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy

Autophagy modulation as a potential therapeutic target for diverse diseases

Molecular neurobiology of mTOR

Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells

Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease

Parkinson's disease: mechanisms and models

P2888

s12035-017-0496-4

P304

2403-2419

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12035-017-0496-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Salvatore Cuzzocrea

Marika Cordaro

Rosalia Crupi

P577

2017-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28357809

http://www.w3.org/2001/XMLSchema#string

Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

about

P2860

P2860

Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698